CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Beijing Northland Biotech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Beijing Northland Biotech Co Ltd
A406, Biotechnology Business Incubator
No. 5, Shangdi Kaituo Road, Haidian Dist
Phone: +86 1082890893p:+86 1082890893 BEIJING, BEJ  100085  China Ticker: 430047430047
Business Summary
Beijing Northland Biotech Co Ltd is a China-based company mainly engaged in the research and development, production and sales of biopharmaceuticals. The Company's main products include gene therapy drugs, recombinant protein drugs and ophthalmic drugs. Its products are mainly used to treat cardiovascular diseases, metabolic diseases, rare diseases and other diseases. The Company is also engaged in the provision of technical services and commissioned processing services. The Company mainly conducts its businesses in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

General Information
Number of Employees: 165 (As of 6/30/2023)
Outstanding Shares: 274,873,974 (As of 1/25/2024)
Shareholders: 7,354
Stock Exchange: BJS
Fax Number: +86 1082890892


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024